Artal Group S.A. Fusion Pharmaceuticals Inc. Transaction History

Artal Group S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$2.48 - $9.65 $1.78 Million - $6.94 Million	-719,500 Reduced 41.71%	1,005,500 $9.66 Million
Q2 2023 Aug 11, 2023	SELL	$3.47 - $5.33 $867,500 - $1.33 Million	-250,000 Reduced 12.66%	1,725,000 $8.06 Million
Q1 2023 May 12, 2023	BUY	$3.03 - $5.13 $3.71 Million - $6.28 Million	1,225,000 Added 163.33%	1,975,000 $7.45 Million
Q2 2021 Aug 13, 2021	BUY	$7.97 - $10.66 $1.68 Million - $2.25 Million	210,736 Added 39.08%	750,000 $6.06 Million
Q1 2021 May 14, 2021	BUY	$9.75 - $13.09 $5.26 Million - $7.06 Million	539,264 New	539,264 $5.78 Million

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.